TransPerfect Life Sciences Announces ECOA LingCert Program

TransPerfect Life Sciences Announces ECOA LingCert Program

This new accreditation certifies the eCOA technology platform

TransPerfect Life Sciences, a leading provider of services and technologies supporting global clinical trials and product development for the biopharmaceutical industry, today announced the use of its certification solution to certify its electronic clinical outcome assessment (eCOA) technology platform based on host capacity. eCOA is local content aligned with industry standards, best practices and sponsorship requirements.

The solution, called the LingCert eCOA, has three levels of certification: Silver, Gold and Platinum. Each level is awarded based on ability to meet operational success criteria across four platform categories:

  • Content management
  • internationalization
  • Test after translation
  • Ability to reuse content

Some recent recognition in the field, including the ECOA Clario tablet, has helped draw attention to platform enhancements that offer 360-degree progress.

“TransPerfect's new certification helps differentiate COA offerings in the marketplace by making it easier to demonstrate that we provide a superior experience to our customers and their patients,” said Terry Burke, Clario's Executive Vice President of eCOA.

LingCert's eCOA was designed to alleviate the challenge of delivering electronically migrated COAs to clinical trial participants, where any errors ultimately increase costs and delays. With this certification, the eCOA platform is also well positioned to reduce translation costs and improve the overall quality of eCOA by meeting backers' expectations.

The newly recognized clinical ink platform paves the way for additional levels of process excellence across the company's technology suite.

Megan Petrelak, Executive Vice President of Client Experience at Clinical Inc. Partnership for Harmonized Structures allows us to reliably measure compliance with industry standards and helps us characterize the conversations with sponsors that are most important to them.

See also  Exploring the Fascinating World of Sciences

“We are excited to introduce the LingCert eCOA certification program,” said Phil Shaw, President and CEO of TransPerfect. “This certification provides our customers and life science partners with a one-stop approach to hosting local ECOA materials.”

Learn more about TransPerfect's eCOA solutions at

About Clario

Clario is a leading healthcare research and technology company providing our partners with the most comprehensive clinical data in the pharmaceutical, biotechnology and medical device industries. Through decentralized, hybrid, and on-site testing, our deep scientific expertise, global reach, and industry-wide endpoint technology platforms enable our partners to change lives. Clario's digital eCOA solution has enabled hybrid and decentralized clinical trials (DCT) for more than 20 years, enabling sponsors to collect high-quality endpoint data from any method and any location, enhancing patient experience and versatility. Clario has the only technology platform that integrates eCOA, cardiac safety, medical imaging, precision movement and respiratory endpoints. Clario's global team of 30 medical centers in nine countries has helped conduct more than 19,000 studies and received 870 regulatory approvals for more than 5 million patients in 120 countries. Our innovations have transformed 50 years of clinical experience.

About Clinical Ink

Clinic Inc. It is a global life sciences company that brings data, technology and patient research together. Our deep expertise in treatment combined with advances in live data collection, eCOA, eConsent, telemedicine, neurocognitive testing, and digital biomarkers is setting the industry standard for data accuracy and opening up a new generation of clinical trials. Using digital data, we are helping sponsors, client service providers, investigators, and patients recreate decentralized trials and rewrite clinical development experiences.

See also  Looking Into Alimera Sciences's Return On Capital Employed

About Transperfect Life Sciences

TransPerfect Life Sciences supports the global development and commercialization of medicines, treatments and devices designed to improve and save lives. Our end-to-end solutions include eTMF technology, eClinical, TMF paper migration, pharmacovigilance and security solutions, translation and language services, and call center support. With offices in over 100 cities worldwide, Transperfect is the ideal partner to ensure the global impact of your global launch. For more information, visit our website at

About Transperfect

TransPerfect is the world's largest provider of enterprise language and technology solutions. From offices in more than 100 cities on six continents, TransPerfect offers customers worldwide a variety of services in more than 200 languages. More than 6,000 organizations worldwide use TransPerfect GlobalLink® technology to simplify multilingual content management. With an unparalleled commitment to quality and customer service, TransPerfect is fully ISO 9001 and ISO 17100 certified. Transperfect is headquartered in New York with regional headquarters in London and Hong Kong. For more information about TransPerfect, visit

Leave a Comment